Search
Sumario de resultados
TIpos de contenido
Fecha
-
CompanyXENOPAT
-
NewNatac increases its EBITDA by 66.5% in 2025, surpassing €23 million
The figure is significantly above the €20 million previously forecast and communicated to the market
-
-
EventBioConnect 2026
-
-
NewBiotechnological innovation: key to healthier soils and resilient agricultural production
On the World Day of Action Against Global Warming, we highlight the strategic role of biotechnology in promoting more sustainable and resilient agricultural systems aligned with the EU’s climate
-
Press releaseBiotechnological innovation: key to healthier soils and resilient agricultural production
The EU has approved Directive (EU) 2025/2360 and the report EU Agricultural Outlook 2025–2035, establishing key soil health indicators and promoting more sustainable and efficient agricultural models
-
EventBIO EUROPE 2026
-
NewThe future of Clinical Trials
Digital transformation and artificial intelligence are redefining the traditional model of clinical trials.
-
NewArchivel Farma renews GMP certification and strengthens its transformation into a CDMO
The GMP renewal is the result of a comprehensive process to upgrade the facilities, manufacturing processes, and contamination control systems.
-
CompanyPONS IP
-
-
EventBIOTECHX EUROPE
-
EventCPHI EUROPE
-
-
-
-
-
EventBIO ASIA TAIWÁN
-
-
EventGenesis 2026
